# Nabilone in Cannabis Users With PTSD

> **NCT03251326** · PHASE1,PHASE2 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 4 (actual)

## Conditions studied

- Cannabis
- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Nabilone
- **DRUG:** Cannabis
- **DRUG:** Propranolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03251326
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2022-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251326, "Nabilone in Cannabis Users With PTSD". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03251326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*